子宫内膜癌淋巴结切除术与外照射放疗使用的地理差异:基于人群数据的横断面分析
调整肿瘤和患者特征后,淋巴结切除术比例范围为5%(95%CI 4-6%)至48%(95%CI 45-52%),外照射放疗范围为10%(95%CI 7-12%)至31%(95%CI 28-33%)。作者认为淋巴结切除术可能用于分诊外照射放疗,差异可能源于局部指南不同,建议澄清英国推荐。
要点
- 调整病理分级、年龄、合并症、贫困、民族和FIGO分期后,各癌症联盟淋巴结切除术比例从5%至48%不等。
- 外照射放疗调整后比例从10%至31%不等,存在明显地理差异。
- 作者认为淋巴结切除术使用高而外照射放疗使用低时,淋巴结切除术可能用于分诊外照射放疗。
核心结论
- 作者认为淋巴结切除术使用高而外照射放疗使用低时,淋巴结切除术可能用于分诊外照射放疗。
- 作者认为这种差异可能源于局部子宫内膜癌管理指南的不同,提示英国推荐应予以澄清。
研究设计与样本
- 研究为基于人群数据的横断面分析,使用英格兰癌症登记数据并链接化疗、放疗和医院 episodes 统计数据库。
- 比较19个癌症联盟间接受淋巴结切除术和/或外照射放疗的比例,并使用两个独立 logistic 回归模型评估调整肿瘤和患者特征对差异的影响。
主要发现
- 调整病理分级、年龄、合并症、贫困、民族和(仅外照射放疗)FIGO分期后,各癌症联盟淋巴结切除术调整比例范围为5%(95%CI 4-6%)至48%(95%CI 45-52%)。
- 调整相同变量后,各癌症联盟外照射放疗调整比例范围为10%(95%CI 7-12%)至31%(95%CI 28-33%)。
- 识别出不同临床实践模式:一个癌症联盟淋巴结切除术显著高于平均水平且外照射放疗显著低于平均水平;三个淋巴结切除术和外照射放疗均高使用;一个淋巴结切除术低使用而外照射放疗高使用;三个两者均低使用。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: To quantify geographic variation in the use of lymphadenectomy and/or external-beam radiotherapy (EBRT) for endometrial cancer in England. DESIGN: Cross-sectional analysis of population-based data. SETTING: English cancer registry data, linked to chemotherapy, radiotherapy and hospital episodes statistics data. POPULATION: Twenty-two thousand four hundred and eighty-three women with endometrial cancer presenting without clinical or radiological evidence of distant metastatic spread, diagnosed in England from 2013 to 2016. METHODS: Proportions of patients receiving lymphadenectomy and/or EBRT were compared across 19 Cancer Alliances, to identify variations in clinical practice. Two separate logistic regression models assessed the impact on variation of adjustment for tumour and patient characteristics. MAIN OUTCOME MEASURES: Receipt of lymphadenectomy, receipt of EBRT. RESULTS: There was substantial variation by Cancer Alliance in the adjusted proportion of women with endometrial cancer receiving lymphadenectomy (range 5% [95% CI 4-6%] to 48% [95% CI 45-52%]) and EBRT (range 10% [95% CI 7-12%] to 31% [95% CI 28-33%]), after adjusting for variation in pathological grade, age, comorbidities, deprivation, ethnic group and (EBRT only) FIGO stage. Different approaches to clinical practice were identified; (i) one Cancer Alliance had significantly higher than average lymphadenectomy and significantly lower than average EBRT use, (ii) three had high use of both lymphadenectomy and EBRT, (iii) one had low lymphadenectomy use and high EBRT use, and (iv) three had low use of both lymphadenectomy and EBRT. CONCLUSIONS: Lymphadenectomy is probably used to triage for EBRT when lymphadenectomy use is high and EBRT use is low. This is probably a result of variation in local endometrial cancer management guidelines, suggesting that UK recommendations should be clarified. TWEETABLE ABSTRACT: There is geographic variation in England in the use of lymphadenectomy and radiotherapy to treat endometrial cancer.
引用
- White B, Nordin A, Fry A, et al. Geographic variation in the use of lymphadenectomy and external-beam radiotherapy for endometrial cancer: a cross-sectional analysis of population-based data. BJOG. 2019. PMID: 31449731. doi:10.1111/1471-0528.15914
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。